Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Exercise/Conversion of 961 APVO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 961 | n/a |
| Aug 8, 2025 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 17,300 | n/a |
| Jul 21, 2025 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 5 | n/a |
| Mar 4, 2025 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 3 | n/a |
| Aug 9, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 42 | n/a |
| Jul 19, 2024 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 12,825 | n/a |
| Mar 5, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 5,500 | n/a |
| Jan 30, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 1,833 | n/a |
| Aug 10, 2023 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 11,979 | n/a |
| Mar 7, 2023 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 3,666 | n/a |